2-tert-butylhydroquinone has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeolu, AI; Amobi, CA; Chikezie, CC; Egedigwe-Ekeleme, AC; Eleazu, CO; Eleazu, KC; Igwe, VM; Kalu, AO; Kalu, WO; Kanu, S; Njemanze, CC; Obeten, UN; Obi, V; Odii, BC; Ogunwa, SC; Okoh, PN; Okorie, UC; Onyia, CJ; Onyia, S; Ossai, P; Ozor, G; Ugada, OJ | 1 |
| Emamgholipour, S; Emrani, AS; Esmaillzadeh, A; Forootani, B; Jambarsang, S; Khayyatzadeh, SS; Pourrajab, F; Salehi-Abarghouei, A; Sasanfar, B; Yasini Ardakani, SA; Zademohammadi, F | 1 |
1 trial(s) available for 2-tert-butylhydroquinone and Metabolic Syndrome
| Article | Year |
|---|---|
The impact of a blend of Pistacia atlantica seed and canola oil compared with a blend of corn-canola oil with synthetic antioxidant and corn-canola oil without synthetic antioxidant on oxidative stress markers in patients with metabolic syndrome: protocol
Topics: Antioxidants; Corn Oil; Cross-Over Studies; Humans; Metabolic Syndrome; Oxidative Stress; Pistacia; Randomized Controlled Trials as Topic; Rapeseed Oil; Zea mays | 2023 |
1 other study(ies) available for 2-tert-butylhydroquinone and Metabolic Syndrome
| Article | Year |
|---|---|
Tert-butylhydroquinone abrogates fructose-induced insulin resistance in rats via mitigation of oxidant stress, NFkB-mediated inflammation in the liver but not the skeletal muscle of high fructose drinking rats.
Topics: Animals; Fructose; Inflammation; Insulin Resistance; Liver; Male; Metabolic Syndrome; Metformin; Muscle, Skeletal; Oxidants; Rats | 2022 |